Genentech_ GO40554_Ph1b_II_B cell lymphoma - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn how safe and effective the study drug, mosunetuzumabm, is for treating DLBCL.
Large B-Cell Lymphoma
Who Can Participate in the Study?
-Have untreated DLBCL
-Have had one chemotherapy course with some response
What is Involved?
If you choose to be in this study you will:
-Be placed in Group A (had treatment for DLBCL) or Group B (never treated before)
-Group A will take the study drug (Mosunetuzumab) into the vein for up to 5 months
-Group B will take the study drug (Mosunetuzumab) into the vein for up to 13 months